2Inoue A,Seto M,Sugita S,et al.Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary[J].Molecular Brain Res,1998,55:285-292.
4Marder SR,McQuade RD,Stock E,et al.Aripiprazole in the treatment of schizophrenia:safety and tolerability in short-term,placebo-controlled trials[J].Schizophr Res,2003,61:123-136.
5久住一郎,小山司.抗精神病藥の開發動向と問題点[J].臨床精神醫學,2004,263－267.
6Bowles TM, levin GM. Aripiprazole : A new atypical antipsychotic drug [ J ]. Ann pharmacother, 2003,37 : 687-694.
7Murasaki M. AD-5423 versus haloperidol in the treatment of schizophrenic patients: results of the Japan multicentle, double-blind trial [ J ]. Eur Neuropsychopharmacol, 2002,12 : 5268.
8Gunasekara NS, Spencer CM, Keating GM. Ziprasidone : a review of its use irt schizophrenia and schizoaffective disorder[ J ]. Drugs, 2002,62 :1217-1251.
10Ogasa M,kimura T, Boylan M, et al. SM-13496 in patients with acute exacerbation of schizophrenia: a two-dosc double-blind phase Ⅱ comparison with placebo [ J ]. Schizophr Res, 2003,60 ( Suppl ) : 297.
